Silver nanoparticles combine with Nigella sativa oil to potentiate apoptosis in cervical cancer

银纳米颗粒与黑种草油结合可增强宫颈癌细胞凋亡。

阅读:2

Abstract

Cervical cancer remains a global health challenge, necessitating innovative therapies that enhance tumor-specific apoptosis while sparing healthy tissues. This study investigates the combined potential of Nigella sativa oil (NS) and silver nanoparticles (AgNPs) in inducing apoptosis in HeLa cervical cancer cells. NS, rich in thymoquinone, modulates apoptotic pathways (Bax/Bcl-2, p53, caspase-9), while AgNPs trigger oxidative stress and genomic instability. We hypothesized that their combination would amplify apoptotic efficacy through complementary mechanisms. HeLa cells were treated with AgNPs (1–10 µg/mL) and with a combination of a selected dose of AgNPs (5 µg/mL) and NS (100–250 µg/mL). Cytotoxicity, apoptosis (as assessed by Annexin V/PI staining and acridine orange/ethidium bromide staining), and gene expression (Quantitative Real-Time Polymerase Chain Reaction, qRT-PCR) were evaluated. Gas Chromatography-Mass Spectrometry (GC-MS) confirmed NS’s bioactive composition, while Scanning Electron Microscopy (SEM)/Fourier Transform Infrared Spectroscopy (FTIR) characterized AgNPs. The results demonstrated dose-dependent apoptosis. The most effective combination was 5 µg/mL AgNPs + 150 µg/mL NS, which induced 29.1% early apoptosis. Pro-apoptotic genes (BAX, BAK, p53, caspase-9) were upregulated (3.2–4.8-fold), while BCL-2 was suppressed (0.28-fold). This study unveils a novel combinatorial strategy leveraging NS’s epigenetic regulation and AgNPs’ cytotoxic effects, suggesting a promising avenue for future research. The findings underscore the potential of plant-nanoparticle synergy in oncology. Future in vivo studies are warranted to validate the clinical applicability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-026-36082-4.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。